Tinavi Medical Technologies Co Ltd (688277) — Working Capital to Net Assets Ratio
Tinavi Medical Technologies Co Ltd (688277) has a Working Capital to Net Assets ratio of 20.0% as of March 2026. Working capital of CN¥238.86 Million (current assets of CN¥369.08 Million minus current liabilities of CN¥130.22 Million) is measured against net assets of CN¥1.19 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. See Tinavi Medical Technologies Co Ltd net asset quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Tinavi Medical Technologies Co Ltd Working Capital to Net Assets (2013–2025)
This chart shows how Tinavi Medical Technologies Co Ltd's Working Capital to Net Assets ratio has evolved across 13 annual periods from 2013 to 2025. As of March 2026, the ratio stands at 20.0%, reflecting working capital of CN¥238.86 Million against net assets of CN¥1.19 Billion CNY. Check Tinavi Medical Technologies Co Ltd tangible book value ratio to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for Tinavi Medical Technologies Co Ltd (2013–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Tinavi Medical Technologies Co Ltd from 2013 to 2025, covering 13 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see how much is Tinavi Medical Technologies Co Ltd worth.
| Year | WC/NA Ratio | Working Capital (CNY) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 9.3% | CN¥279.31 Million | CN¥3.01 Billion | CN¥442.89 Million | CN¥163.58 Million | ▼ -12.7 pp |
| 2024 | 22.0% | CN¥281.37 Million | CN¥1.28 Billion | CN¥437.97 Million | CN¥156.60 Million | ▼ -4.0 pp |
| 2023 | 26.0% | CN¥321.76 Million | CN¥1.24 Billion | CN¥488.80 Million | CN¥167.04 Million | ▲ +6.8 pp |
| 2022 | 19.2% | CN¥215.03 Million | CN¥1.12 Billion | CN¥373.41 Million | CN¥158.38 Million | ▼ -17.7 pp |
| 2021 | 36.9% | CN¥394.19 Million | CN¥1.07 Billion | CN¥507.42 Million | CN¥113.23 Million | ▼ -32.6 pp |
| 2020 | 69.5% | CN¥713.75 Million | CN¥1.03 Billion | CN¥794.32 Million | CN¥80.57 Million | ▼ -2.8 pp |
| 2019 | 72.3% | CN¥431.33 Million | CN¥596.34 Million | CN¥527.64 Million | CN¥96.31 Million | ▼ -8.6 pp |
| 2018 | 80.9% | CN¥453.61 Million | CN¥560.61 Million | CN¥547.72 Million | CN¥94.12 Million | ▼ -0.3 pp |
| 2017 | 81.2% | CN¥137.57 Million | CN¥169.41 Million | CN¥571.23 Million | CN¥433.66 Million | ▼ -27.2 pp |
| 2016 | 108.4% | CN¥148.13 Million | CN¥136.62 Million | CN¥161.81 Million | CN¥13.67 Million | ▲ +15.0 pp |
| 2015 | 93.4% | CN¥190.54 Million | CN¥203.98 Million | CN¥198.52 Million | CN¥7.98 Million | ▲ +2.3 pp |
| 2014 | 91.1% | CN¥48.14 Million | CN¥52.84 Million | CN¥58.82 Million | CN¥10.67 Million | ▲ +11.5 pp |
| 2013 | 79.6% | CN¥23.57 Million | CN¥29.60 Million | CN¥28.91 Million | CN¥5.34 Million | — |